Ionis Pharmaceuticals, Inc.’s Post

Want to learn more about how our teams at Ionis keep the patient perspective top-of-mind? Wonder what it takes to create awareness of new medicines for rare diseases? Dawn Henson, brand lead for our investigational medicine for hereditary angioedema (#HAE), is here to answer your questions. Find out how Dawn built a culture of caring and a team of high performing individuals driven to help patients. Ask your questions for Dawn in the comments!

  • No alternative text description for this image
DJ Hanson

Founder & Managing Partner at BlueprintNYC

2w

Love the phrase "Culture of Caring". How do you thread the needle of illustrating care and support, while still holding your team accountable to high performance?

Stephanie Ellis

Commercial Leader, Early/Late-Stage Commercial Development, Marketing, Launch, Change Management, Independent Consulting, Alzheimer's Disease, Vaccines, Hemophilia, Women's Health.

1w

Congratulations Dawn! 🎉It has been a minute since we worked together, I am excited to see your success!

Like
Reply
Melinda Decker

Global BioPharmaceutical & Digital Health Leader | Fractional Chief Commercial Officer (CCO) & Advisor

1w

Fabulous to see you highlighted, Dawn! Hope you, Bruce and the kids are well.

See more comments

To view or add a comment, sign in

Explore topics